Delivery Order SPE2DR25D2010-SPE2DR26F4YYD
- Not listed
- The Defense Logistics Agency awarded a $18,044.80 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price contract, with a completion date of September 11, 2025, represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of Durolane 60 mg/3 ml syringes with a ceiling value of $12,697.01. This is a firm fixed-price delivery order with an ultimate completion date of September 29, 2025, and represents a non-set-aside competitive award. The order will be performed at the contractor's facility in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based injectable used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $4,949.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on July 23, 2025, with an ultimate completion date of July 24, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order valued at $1,593.95 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 mL syringes on a firm fixed price basis. The contract was competitively awarded without set-aside designation and is scheduled for completion by April 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,105.80 to AmerisourceBergen Drug Corp for the supply of Durolane 60 mg/3 ml syringes. This firm fixed-price, competitively awarded contract (non-set-aside) was executed on June 27, 2025, with an ultimate completion date of June 30, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based injectable used for osteoarthritis treatment, indicating...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $38,174.77 to AmerisourceBergen Drug Corp for the supply of Durolane 60mg/3ml injections on July 8, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 4, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in...
- The Defense Logistics Agency awarded a $8,453.04 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Durolane 60 mg/3 mL syringes. This firm fixed-price contract, with a completion date of July 29, 2025, represents a competitively awarded non-set-aside procurement executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The products will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $9,965.97 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on September 2, 2025, with completion expected by September 3, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Durolane is a hyaluronic acid-based intra-articular injection used for osteoarthritis treatment, representing a specialized...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $1,275.20 firm fixed-price delivery order for Durolane 60 mg/3 ml syringes on June 5, 2025, with an ultimate completion date of June 6, 2025. This non-competitive, non-set-aside award is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Durolane 60 mg/3 ml syringes with a contract value of $12,633.03 and a completion date of October 31, 2025. Durolane is a hyaluronic acid-based intra-articular injection used for osteoarthritis treatment. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The place of performance is AmerisourceBergen's...
- SPE2DR25D2010Indefinite Delivery Contract
- SPE2DR25D2010-SPE2DR26F4YYDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,785.01 to AmerisourceBergen Drug Corp for Durolane 60 mg/3 mL syringes on November 14, 2025, with an ultimate completion date of November 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The prime contractor, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location and is a major pharmaceutical distributor serving the federal medical procurement sector. AmerisourceBergen Drug Corp leverages its comprehensive pharmaceutical supply agreement with DLA to fulfill individual delivery orders supporting military healthcare programs and other federal healthcare systems. Durolane is a hyaluronic acid injection used for osteoarthritis pain management, reflecting the company's role in supplying specialized medical commodities across multiple therapeutic domains. The DLA Medical Supply Chain utilizes AmerisourceBergen as a critical vendor for medications, medical devices, vaccines, and related healthcare products needed to support Defense Health Agency operations and broader military healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.8k | 11/14/25 |